Name and PositionDr Max Yates
Contact DetailsMain Telephone Number:01603 288678
Position: Clinical Associate Professor and Honorary Consultant Rheumatologist
Secretary: Teresa Abbott
Special Clinical Interests: Inflammatory polyarthritis, polymyalgia rheumatica, outcome measures, clinical trials
Research Interests: Epidemiology, aetiological factors, risk factors for rheumatic disease onset and progression, inflammatory polyarthritis, polymyalgia rheumatica, outcome measures
Current Membership of Professional, National and Regional Bodies: Member of the Royal College of Physicians, General Medical Council, British Society for Rheumatology, Fellow of the Higher Education Authority.
Universities and Degrees: University of Leicester: BSc (Hons), University of East Anglia: MSc (merit), MBBS, PhD
GMC Number: 6155845
Professional Profile: Dr Max Yates trained in the Eastern region with fellowship experience in London at the Royal Free and Moorfields Eye Hospitals. His PhD investigated risk factors for onset and progression amongst individuals diagnosed with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) and subsequently was appointed as a NIHR Clinical Lecturer whilst finishing specialist training in rheumatology in 2018 before gaining tenure in 2019. He runs the Academic Specialised Foundation Programme https://heeoe.hee.nhs.uk/foundation/foundation-recruitment/academic-training , which represents the first step on the rung for Integrated Academic Training for doctors.
He is an active member of consortia and international groups including the UK Biobank Eye and Vision Consortium https://www.ukbiobankeyeconsortium.org.uk/ and the Outcome Measures in Rheumatology (OMERACT) working groups, the latter of which he co-chairs the PMR working group https://omeract.org/working-groups/polymyalgia-rheumatica/
He investigates aetiological hypotheses using statistical models. His current interests include investigating comorbidity in PMR, GCA and inflammatory polyarthritis and using retinal images to validate vascular disease states in these conditions. He also has a research interest in the pathway management and care of people with rheumatic diseases and the use of electronic tools to improve process management, autonomy, and efficiency.